MedTrace Logo

Mechanistic Clinical Trial of Advanced Imaging for CRT

NCT03398369 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2020-02-06

No results posted yet for this study

Summary

This is a mechanistic clinical trial with randomization to guidance for the CRT procedure using cardiac magnetic resonance (CMR) and computed tomography angiography (CTA) versus a standard procedure.

Conditions

  • Heart Failure, Systolic

Interventions

DIAGNOSTIC_TEST

CMR/CTA Guidance for CRT

The intervention is the use of CMR and CTA to determine the optimal pacing site in the left ventricle for cardiac resynchronization therapy (CRT) and guide left ventricular lead placement.

Sponsors & Collaborators

  • University of Virginia

    lead OTHER

Principal Investigators

  • Kenneth C Bilchick, MD · University of Virginia Health System

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-05
Primary Completion
2025-01-15
Completion
2025-01-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03398369 on ClinicalTrials.gov